Prospective and randomized study of the antihypertensive effect and tolerability of three antihypertensive agents, losartan, amlodipine, and lisinopril, in hypertensive patients

Heart and Vessels

Volumn 19, Issue 1, 2004, Pages 13-18

  Wu, San Chiang ^a   Liu, Chun Peng ^b   Chiang, Hung Ting ^b   Lin, Shoa Lin ^b  

^a True Generation Hospital   (Taiwan)

^b NATIONAL YANG MING UNIVERSITY   (Taiwan)

Author keywords

Angiotensin receptor antagonist; Angiotensin converting enzyme inhibitor; Calcium channel blocker; Hypertension

Indexed keywords

ALANINE AMINOTRANSFERASE; ALBUMIN; AMLODIPINE; ANGIOTENSIN 2 RECEPTOR ANTAGONIST; ANTIHYPERTENSIVE AGENT; ASPARTATE AMINOTRANSFERASE; CALCIUM; CALCIUM CHANNEL BLOCKING AGENT; CHOLESTEROL; CREATININE; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; GLUCOSE; HIGH DENSITY LIPOPROTEIN; LISINOPRIL; LOSARTAN; LOW DENSITY LIPOPROTEIN; NITROGEN; POTASSIUM; SODIUM; TRIACYLGLYCEROL; UREA; URIC ACID;

ADULT; AGED; AMBULATORY CARE; ANTIHYPERTENSIVE ACTIVITY; ARTICLE; BIOCHEMISTRY; BLOOD PRESSURE REGULATION; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; COUGHING; DIASTOLIC BLOOD PRESSURE; DISEASE SEVERITY; DIZZINESS; DRUG EFFICACY; DRUG TOLERABILITY; FEMALE; HEADACHE; HUMAN; HYPERTENSION; LEG EDEMA; MAJOR CLINICAL STUDY; MALE; NOSE CONGESTION; PRIORITY JOURNAL; PROSPECTIVE STUDY; RANDOMIZED CONTROLLED TRIAL; SITTING; STATISTICAL SIGNIFICANCE; SYSTOLIC BLOOD PRESSURE; TASTE DISORDER; TITRIMETRY; UREA NITROGEN BLOOD LEVEL;

AGED; AMLODIPINE; ANGIOTENSIN-CONVERTING ENZYME INHIBITORS; ANTIHYPERTENSIVE AGENTS; BLOOD PRESSURE; CALCIUM CHANNEL BLOCKERS; COUGH; FEMALE; HUMANS; LISINOPRIL; LOSARTAN; MALE; MIDDLE AGED; PROSPECTIVE STUDIES;

EID: 0347416924     PISSN: 09108327     EISSN: None     Source Type: Journal    
DOI: 10.1007/s00380-003-0724-x     Document Type: Article

References (35)

1. Kloner RA, Vetrovec GW, Materson BJ, Levenstein M (1998) Safety of long-acting dihydropyridine calcium channel blockers in hypertensive patients. Am J Cardiol 81:163-169
2. Abernethy DR (1994) An overview of the pharmacokinetics and pharmacodynamics of amlodipine in elderly persons with systemic hypertension. Am J Cardiol 73:10A-17A
3. Dimenas E, Wallander MA, Svardsudd K, Wiklund I (1991) Aspects of the quality of life on treatment with felodipine. Eur J Clin Pharmacol 40:141-147
4. Forhlich ED (1992) Obesity hypertension: converting enzyme inhibitors and calcium antagonists. Hypertension. 19(suppl I):I-119-I-123
5. Pollare T, Lithell H, Berne C (1989) A comparison of the effects of hydrochlorothiazide and captopril on glucose and lipid metabolism in patients with hypertension. N Engl J Med 321:868-873
6. Dzau VJ (1987) Implications of local angiotensin production in cardiovascular physiology and pharmacology. Am J Cardiol 59: 59A-65A
7. Sanchez RA, Marco E, Gilbert HB, Raffaele P, Brito M, Gimenez M, Moledo LI (1985) Natriuretic effects and changes in renal hemodynamics induced by enalapril in essential hypertension. Drugs 30:149-158
8. Timmermans PB, Benfield P, Chiu AT, Herblin WF, Wong PC, Smith RD (1992) Angiotensin II receptors and functional correlates. Am J Hypertens 5(part 2):221S-235S
9. Lo MW, Goldberg MR, McCrea JB, Lu H, Furtek CI, Bjornsson TD (1995) Pharmacokinetics of losartan, an angiotensin II receptor antagonist, and its active metabolite EXP 3174 in humans. Clin Pharmacol Ther 58:641-649
10. Gradman AH, Arcuri KE, Goldberg AI, Ikeda LS, Nelson EB, Snavely DB, Sweet CS (1995) A randomized, placebo-controlled, double-blind, parallel study of various doses of losartan potassium compared with enalapril maleate in patients with essential hypertension. Hypertension 25:1345-1350
11. Townsed R, Haggert B, Liss C, Edelman JM (1995) Efficacy and tolerability of losartan versus enalapril alone or in combination with hydrochlorothiazide in patients with essential hypertension. Clin Ther 17:911-923
12. Oparil S, Barr E, Elkins M, Liss C, Vrecenak A, Edelman J (1996) Efficacy, tolerability, and effects on quality of life of losartan, alone or with hydrochlorothiazide, versus amlodipine, alone or with hydrochlorothiazide, in patients with essential hypertension. Clin Ther 18:608-625
13. Wilson TW, Lacourciere Y, Barnes CC (1998) The antihypertensive efficacy of losartan and amlodipine assessed with office and ambulatory blood pressure monitoring. Canadian Cozaar Hyzaar Amlodipine Trial Study Group. Can Med Assoc J 159:469-476
14. Maclean D, Mitchell ET, Wilcox RG, Walker P, Tyler HM (1988) Amlodipine and captopril in moderate-severe essential hypertension. Hum Hypertens 2:127-132
15. Stoked GS, Monaghan JC, Berman K, Ryan M, Campbell DJ (1998) Double-blind crossover study of the interaction between perindopril and amlodipine on blood pressure and hormones related to fluid and electrolyte balance in patients with essential hypertension. Hum Hypertens 12:129-134
16. Anderson TJ, Elstein E, Haber H, Charbonneau F (2000) Comparative study of ACE-inhibition, angiotensin II antagonism, and calcium channel blockade on flow-mediated vasodilation in patients with coronary disease (BANFF study). J Am Coll Cardiol 35:60-66
17. Brunner HR, Christen Y, Munafo A, Lee RJ, Waeber B, Nussberger J (1992) Clinical experience with angiotensin II receptor antagonist. Am J Hypertens 121:999-1006
18. Case DB, Wallace JM, Keim HJ, Sealey JE, Laragh JH (1976) Usefulness and limitation of saralasin, a weak competitive agonist of angiotensin II, for evaluating the renin and sodium factors in hypertensive patients. Am J Med 60:825-836
19. Varrone J (1991) The efficacy and safety of amlodipine in the treatment of mild and moderate essential hypertension in general practice. J Cardiovasc Pharmacol 17 (suppl 1):S30-S33
20. Hansson L, Svensson A, Dahlöf B, Eggerstew R (1992) Drug treatment of hypertension. In: Robertson JIS (ed) Handbook of hypertension, vol. 15. Elsevier, Amsterdam, pp 655-708
21. Dzau VJ (1988) Evolving concepts of the renin-angiotensin system. Focus on renal and vascular mechanism. Am J Hypertens 1:334S-337S
22. Dahlöf B, Lindholm LH, Carney S, Pentikainen PJ, Ostergren J, Lindholm LH, Carney S, Pentikainen PJ, Ostergren J (1997) Main results of the losartan versus amlodipine study on drug tolerability and psychologic general well being. J Hypertens 151:1327-1335
23. Tikkanen I, Omvik P, Jensen HE (1995) Comparison of the angiotensin II antagonist losartan with angiotensin converting inhibitor enalapril in patients with essential hypertension. J Hypertens 13:1343-1351
24. Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure (1997) The sixth report of the Joint National Committee (JNC-VI) on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure. Arch Intern Med 157:2413-2446
25. Dahlöf B, Devereuz RB, Kjeldsen SE, Julius S, Beevers G, Faire U, Fyhrquist F, Ibsen H, Kristiansson K, Lederballe-Pedersen O, Lindholm LH, Nieminen MS, Omvik P, Oparil S, Wedel H (2002) The LIFE Study Group. Cardiovascular morbidity in the losartan intervention for endpoint reduction in hypertension study (LIFE): a randomized trial against atenolol. Lancet 359:995-1003
26. Lindholm LH, Ibsen H, Dahlöf B, Devereux RB, Beevers G, de Faire U, Fyhrquist F, Julius S, Kjeldsen SE, Kristiansson K, Lederballe-Pedersen O, Nieminen MS, Omvik P, Oparil S, Wedel H, Aurup P, Edelman J, Snapinn S (2002) The LIFE Study Group. Cardiovascular morbidity and mortality in patients with diabetes in the losartan intervention for endpoint reduction in hypertension study (LIFE): a randomized trial against atenolol. Lancet 359: 1004-1010
27. Rake EC, Breeze E, Fletcher AE (2001) Quality of life and cough on antihypertensive treatment: a randomized trial of eprosartan, enalapril and placebo. J Hum Hypertens 15:863-867
28. Goldszer RC, Lilly LS, Solomon HS (1988) Prevalence of cough during angiotensin-converting enzyme inhibitor therapy. Am J Med 85:887
29. Gibson GR (1989) Enalapril-induced cough. Arch Intern Med 149:2701-2703
30. Yeo WW, Ramsay LE (1990) Persistent dry cough with enalapril: incidence depends on the method used. J Hum Hypertens 4:517-520
31. Sebastian JL, Mckinney WP, Kaufman J, Young MJ (1991) Angiotensin converting enzyme inhibitors and cough. Chest 99:36-39
32. Hood S, Nicholls MG, Gilchrist NL (1987) Cough with angiotensin converting-enzyme inhibitors. NZ Med J 100:6-7
33. Chan WK, Chan TY, Luk WK, Leung VK, Li TH, Critchey JA (1993) A high incidence of cough in Chinese subjects treated with angiotensin converting enzyme inhibitors. Eur J Clin Pharmacol 44:299-300
34. Woo J, Chan TY (1991) A high incidence of cough associated with combination therapy of hypertension with isradipine and lisinopril in Chinese subjects. Br J Clin Pract 45:178-180
35. Woo KS, Norris RM, Nicholls G (1995) Racial difference in incidence of cough with angiotensin converting enzyme inhibitors (a tale of two cities). Am J Cardiol 75:967-968